Literature DB >> 18802148

Raising the profile of cancer of unknown primary.

Karin A Oien, T R Jeffry Evans.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18802148     DOI： 10.1200/JCO.2008.17.6156

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

Review 1.  [The initial CUP situation and CUP syndrome: pathological diagnostics].

Authors:  R Moll
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

2.  Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.

Authors:  Federico A Monzon; Fabiola Medeiros; Maureen Lyons-Weiler; W David Henner
Journal:  Diagn Pathol       Date:  2010-01-13       Impact factor: 2.644

Review 3.  Cancer microRNAs: from subtype profiling to predictors of response to therapy.

Authors:  Elcie Chan; Daniel Estévez Prado; Joanne Barnes Weidhaas
Journal:  Trends Mol Med       Date:  2011-02-25       Impact factor: 11.951

4.  Clinical presentation of carcinoma of unknown primary: 14 years of experience.

Authors:  Jun Ho Yi; Yoon La Choi; Su Jin Lee; Hee Kyung Ahn; Kyung Kee Baek; Taekyu Lim; Duk Joo Lee; Bo Ram Han; Ha Yeon Lee; Hyun Jung Jun; Jeeyun Lee; Yeon Hee Park
Journal:  Tumour Biol       Date:  2010-08-10

5.  Effective examination methods for identifying the primary origins of metastatic bone tumors of unknown primary origin during the initial visit: A retrospective chart review study.

Authors:  Taketsugu Fujibuchi; Hiroshi Imai; Teruki Kidani; Hiromasa Miura
Journal:  SAGE Open Med       Date:  2022-05-24

6.  Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry.

Authors:  Regine M Schoenherr; Jeffrey R Whiteaker; Lei Zhao; Richard G Ivey; Mary Trute; Jacob Kennedy; Uliana J Voytovich; Ping Yan; Chenwei Lin; Amanda G Paulovich
Journal:  Proteomics       Date:  2012-04       Impact factor: 3.984

Review 7.  MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.

Authors:  Marilena V Iorio; Carlo M Croce
Journal:  EMBO Mol Med       Date:  2012-02-20       Impact factor: 12.137

Review 8.  Oncologist's/haematologist's view on the roles of pathologists for molecular targeted cancer therapy.

Authors:  Ulrich Keller; Nikolas von Bubnoff; Christian Peschel; Justus Duyster
Journal:  J Cell Mol Med       Date:  2010-02-16       Impact factor: 5.310
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.